Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Aghoghovbia
Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor
Journal of Clinical Pharmacology
Pharmacology
Related publications
Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir
Clinical Pharmacokinetics
Pharmacology
Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora a Kinase Inhibitor, in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Tyrosine Kinase Inhibitor and Target Therapy
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent and Selective Covalent Inhibitor of Brutons Tyrosine Kinase
Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer
Experimental & Molecular Medicine
Preclinical Overview of Sorafenib, a Multikinase Inhibitor That Targets Both Raf and VEGF and PDGF Receptor Tyrosine Kinase Signaling
Molecular Cancer Therapeutics
Cancer Research
Oncology
Inhibition of IgE-mediated Secretion From Human Basophils With a Highly Selective Bruton's Tyrosine Kinase, Btk, Inhibitor
International Immunopharmacology
Allergy
Immunology
Pharmacology
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
AAPS Journal
Pharmaceutical Science
